Side effects and good effects from new chemotherapeutic agents. Case 3. Bortezomib in primary refractory plasmacytoma. [electronic resource]
Producer: 20050421Description: 2426-8 p. digitalISSN:- 0732-183X
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Boronic Acids -- therapeutic use
- Bortezomib
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Humans
- Mediastinal Neoplasms -- drug therapy
- Middle Aged
- Plasmacytoma -- drug therapy
- Pyrazines -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.